Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study

von Petersenn, Stephan, Houchard, Aude, Sert, Caroline, Caron, Philippe J.
Veröffentlicht in Pituitary (2019)

Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)

von Adelman, Daphne, Truong Thanh, Xuan-Mai, Feuilly, Marion, Houchard, Aude, Cella, David
Veröffentlicht in Adv Ther (2020)

MON-LB47 An International Simulated Use Study (PRESTO) to Evaluate Nurse Preferences Between the Lanreotide Autogel New Syringe and Octreotide Long-Acting Release Syringe

von Adelman, Daphne T, Truong-Thanh, Xuan-Mai, Feuilly, Marion, Houchard, Aude, Cella, David
Veröffentlicht in J Endocr Soc (2020)

Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study

von Caron, Philippe J., Bevan, John S., Petersenn, Stephan, Houchard, Aude, Sert, Caroline, Webb, Susan M.
Veröffentlicht in Pituitary (2015)

Use of Oral Concomitant Medications in Patients With Acromegaly

von Petersenn, Stephan, Houchard, Aude, Schneider, Maria del Pilar, Ribeiro-Oliveira, Antonio, Neggers, Sebastian Jcmm
Veröffentlicht in J Endocr Soc (2021)

Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study

von Giustina, Andrea, Bronstein, Marcello D., Chanson, Philippe, Petersenn, Stephan, Casanueva, Felipe F., Sert, Caroline, Houchard, Aude, Melmed, Shlomo
Veröffentlicht in Pituitary (2019)

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study

von Caron, Philippe, Brue, Thierry, Raverot, Gérald, Tabarin, Antoine, Cailleux, Anne, Delemer, Brigitte, Renoult, Peggy Pierre, Houchard, Aude, Elaraki, Fatine, Chanson, Philippe
Veröffentlicht in Endocrine (2018)

Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study

von Caron, Philippe, Brue, Thierry, Raverot, Gérald, Tabarin, Antoine, Cailleux, Anne, Delemer, Brigitte, Renoult, Peggy Pierre, Houchard, Aude, Elaraki, Fatine, Chanson, Philippe
Veröffentlicht in Endocrine (2018)

Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Revie...

von Lesén, Eva, Granfeldt, Daniel, Berthon, Anthony, Dinet, Jérôme, Houchard, Aude, Myrenfors, Peter, Björstad, Åse, Björholt, Ingela, Elf, Anna-Karin, Johanson, Viktor
Veröffentlicht in J Cancer (2019)

Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria

von Rinke, Anja, Maintz, Christoph, Müller, Lothar, Weber, Matthias M., Lahner, Harald, Pavel, Marianne, Saeger, Wolfgang, Houchard, Aude, Ungewiss, Hanna, Petersenn, Stephan
Veröffentlicht in Exp Clin Endocrinol Diabetes (2021)

SAGIT(®): clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study

von Giustina, Andrea, Bevan, John S., Bronstein, Marcello D., Casanueva, Felipe F., Chanson, Philippe, Petersenn, Stephan, Thanh, Xuan-Mai Truong, Sert, Caroline, Houchard, Aude, Guillemin, Isabelle, Melmed, Shlomo
Veröffentlicht in Pituitary (2015)

Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice

von Prasad, Vikas, Srirajaskanthan, Raj, Toumpanakis, Christos, Grana, Chiara Maria, Baldari, Sergio, Shah, Tahir, Lamarca, Angela, Courbon, Frédéric, Scheidhauer, Klemens, Baudin, Eric, Truong Thanh, Xuan-Mai, Houchard, Aude, Dromain, Clarisse, Bodei, Lisa
Veröffentlicht in Eur J Nucl Med Mol Imaging (2020)